Abacavir and Etuvetidigene Autotemcel: Interaction Details
AI-assisted, pharmacist-reviewed · AI content regenerated Jul 11, 2026 · Source data updated Jun 30, 2026 · Sources: FDA labeling, DDInter 2.0, cited literature
Abacavir
Etuvetidigene Autotemcel
No brand names on record
How we grade severity & evidence
Severity levels
- Contraindicated: These should generally not be used together.
- Major: Potentially serious — often needs a change or close monitoring.
- Moderate: Can be significant — usually manageable with monitoring.
- Minor: Usually limited clinical impact.
Evidence grades
- Established: Well documented — supported by controlled studies or strong clinical data.
- Probable: Good supporting evidence, though not definitively proven.
- Suspected: Some evidence suggests this interaction, but it is not well established.
- Possible: Limited or conflicting evidence; the interaction may occur.
- Theoretical: Predicted from the drugs' pharmacology; not yet confirmed in people.
Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.
Etuvetidigene autotemcel is a one-time gene therapy. It's made using a special harmless virus (a lentiviral vector) to carry a healthy gene into your own cells. Abacavir is an HIV medicine (an anti-retroviral). Because it works by blocking that same family of viruses, taking it around the time your cells are collected and treated can interfere with how the gene therapy is manufactured, which could make the treatment less effective.
The good news is this is fully manageable with timing. Your care team plans exactly when you pause any anti-retroviral so it doesn't overlap with your gene therapy. Never stop or change abacavir on your own, always talk with your doctor or pharmacist first.
Effect: Abacavir, an antiretroviral, may interfere with manufacturing of etuvetidigene autotemcel, an autologous gene therapy that uses an HIV-1 derived lentiviral vector (LVV) to transduce the patient's cells. Antiretroviral activity against the vector backbone can reduce transduction efficiency and product quality.
- Direction: reduced gene-therapy efficacy (not a PK interaction).
- Evidence: theoretical; severity: major.
- Management: withhold antiretrovirals from at least 1 month prior to mobilization until at least 7 days post-infusion. For required post-exposure prophylaxis, delay therapy until HIV/HTLV western blot and viral load at 6 months post-exposure.
What happens
An increased risk of interference with the manufacturing of etuvetidigene autotemcel
Interaction Deep Dive
The production of etuvetidigene autotemcel can be disrupted by anti-retroviral drugs. Patients should be counseled to refrain from anti-retroviral drugs beginning at least one month before mobilization and continuing until a minimum of 7 days following the etuvetidigene autotemcel infusion. Should a patient need anti-retroviral therapy after being exposed to HIV/HTLV, postpone the start of etuvetidigene autotemcel therapy until both an HIV/HTLV western blot and a viral load assay have been carried out at 6 months after the exposure1.
Why it happens (mechanism)
Interference with the manufacturing of etuvetidigene autotemcel [HIV-1 derived lentiviral vector (LVV)]
How to manage this interaction
This is handled entirely by careful timing, coordinated by your transplant and HIV care teams.
- Anti-retrovirals like abacavir are typically held for at least one month before your cells are mobilized/collected, through at least 7 days after your etuvetidigene autotemcel infusion.
- If you need anti-retroviral treatment after an HIV/HTLV exposure, your team may delay the gene therapy until confirmatory testing (HIV/HTLV western blot and viral load) is done about 6 months later.
Keep taking every medicine exactly as prescribed, and do not stop abacavir on your own. Ask your care team to confirm the exact pause and restart schedule for you.
Management is individual — confirm any change with your pharmacist or prescriber.
Common questions
Can I take Abacavir and Etuvetidigene Autotemcel together?
Abacavir can interfere with the manufacturing of the gene therapy etuvetidigene autotemcel, so your care team will time when you pause it (about a month before collection until at least 7 days after infusion). Follow their schedule and never stop abacavir on your own. Always confirm with your pharmacist or prescriber before making any change.
How serious is the Abacavir and Etuvetidigene Autotemcel interaction?
It is rated major. Potentially serious — often needs a change or close monitoring.
How quickly could this interaction happen?
The documented onset is "unspecified". The timing of this interaction is not well characterized.
How is the Abacavir and Etuvetidigene Autotemcel interaction managed?
This is handled entirely by careful timing, coordinated by your transplant and HIV care teams. Anti-retrovirals like abacavir are typically held for at least one month before your cells are mobilized/collected, through at least 7 days after your etuvetidigene autotemcel infusion. If you need anti-retroviral treatment after an HIV/HTLV exposure, your team may delay the gene therapy until confirmato… Management is individual — always follow your own care team's guidance.
How strong is the evidence for this interaction?
The evidence is graded "theoretical". Predicted from the drugs' pharmacology; not yet confirmed in people.
Questions for your pharmacist
- Does my dose of Abacavir or Etuvetidigene Autotemcel need adjusting while I take them together?
- What symptoms should prompt me to call you or my prescriber right away?
- Does the timing of my doses matter for this combination?
- Is there a safer alternative to one of these medications for me?
References (1)
- Product Information: WASKYRA intravenous injection, etuvetidigene autotemcel intravenous injection. Fondazione Telethon ETS (Per FDA), Rome, Lazio, Italy, 2025.
Keep reading about Abacavir
Keep reading about Etuvetidigene Autotemcel
These medications also interact with supplements
Prescription drugs aren't the whole picture — herbal and dietary supplements can interact with them too. From the evidence-graded Natural Medicines database:
major · moderate · minor — check everything you take with our drug–supplement interaction checker.
Check another combination
Our instant two-drug interaction checker is almost here.
Still have questions about this combination?
Every question gets a real answer from a licensed pharmacist — free, and usually within a day.
Ask the pharmacist